A study highlights a gap in cancer prevention, showing men undergo genetic testing less often yet are more likely to carry ...
The ability of the Geneva homologous recombination deficiency (HRD) test to predict progression-free survival (PFS) in patients with high-grade ovarian cancer treated with poly (ADP-ribose) polymerase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results